Cyclerion Therapeutics Inc (CYCN)
2.88
+0.03
(+1.05%)
USD |
NASDAQ |
May 17, 16:00
2.88
0.00 (0.00%)
After-Hours: 20:00
Cyclerion Therapeutics Total Liabilities (Quarterly): 1.441M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.441M |
| December 31, 2023 | 2.086M |
| September 30, 2023 | 2.341M |
| June 30, 2023 | 4.947M |
| March 31, 2023 | 7.531M |
| December 31, 2022 | 7.627M |
| September 30, 2022 | 8.529M |
| June 30, 2022 | 9.852M |
| March 31, 2022 | 9.491M |
| December 31, 2021 | 11.08M |
| September 30, 2021 | 11.36M |
| Date | Value |
|---|---|
| June 30, 2021 | 10.51M |
| March 31, 2021 | 51.53M |
| December 31, 2020 | 55.88M |
| September 30, 2020 | 56.05M |
| June 30, 2020 | 61.94M |
| March 31, 2020 | 58.49M |
| December 31, 2019 | 88.75M |
| September 30, 2019 | 90.51M |
| June 30, 2019 | 94.31M |
| March 31, 2019 | 17.52M |
| December 31, 2018 | 17.85M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.441M
Minimum
Mar 2024
94.31M
Maximum
Jun 2019
32.21M
Average
10.80M
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 51.05B |
| iBio Inc | 24.82M |
| AbbVie Inc | 140.83B |
| Agile Therapeutics Inc | 26.57M |
| NovaBay Pharmaceuticals Inc | 5.197M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.36M |
| Shareholders Equity (Quarterly) | 9.923M |